{"nct_id":"NCT02760615","title":"Phase 4, Vedolizumab-4002 Post-marketing, Disease-Drug-Drug Interaction Study","status":"WITHDRAWN","status_verified_date":"2020-10","start_date":"2016-11-01","start_date_type":"ESTIMATED","primary_completion_date":"2020-08-01","primary_completion_date_type":"ESTIMATED","completion_date":"2020-08-01","completion_date_type":"ESTIMATED","phases":["PHASE4"],"tickers":["TAK"]}